- Home
- AKTX vs ARKR Comparison
AKTX vs ARKR Comparison
Compare AKTX & ARKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKTX
- ARKR
- Stock Information
- Founded
- AKTX N/A
- ARKR 1983
- Country
- AKTX United States
- ARKR United States
- Employees
- AKTX N/A
- ARKR N/A
- Industry
- AKTX Biotechnology: Pharmaceutical Preparations
- ARKR Restaurants
- Sector
- AKTX Health Care
- ARKR Consumer Discretionary
- Exchange
- AKTX Nasdaq
- ARKR Nasdaq
- Market Cap
- AKTX 41.8M
- ARKR 36.7M
- IPO Year
- AKTX N/A
- ARKR N/A
- Fundamental
- Price
- AKTX $1.18
- ARKR $9.24
- Analyst Decision
- AKTX
- ARKR
- Analyst Count
- AKTX 0
- ARKR 0
- Target Price
- AKTX N/A
- ARKR N/A
- AVG Volume (30 Days)
- AKTX 27.7K
- ARKR 5.8K
- Earning Date
- AKTX 08-18-2025
- ARKR 08-11-2025
- Dividend Yield
- AKTX N/A
- ARKR N/A
- EPS Growth
- AKTX N/A
- ARKR N/A
- EPS
- AKTX N/A
- ARKR N/A
- Revenue
- AKTX N/A
- ARKR $178,516,000.00
- Revenue This Year
- AKTX N/A
- ARKR N/A
- Revenue Next Year
- AKTX N/A
- ARKR N/A
- P/E Ratio
- AKTX N/A
- ARKR N/A
- Revenue Growth
- AKTX N/A
- ARKR N/A
- 52 Week Low
- AKTX $0.85
- ARKR $8.25
- 52 Week High
- AKTX $4.40
- ARKR $17.76
- Technical
- Relative Strength Index (RSI)
- AKTX 44.68
- ARKR 33.53
- Support Level
- AKTX $1.09
- ARKR $9.72
- Resistance Level
- AKTX $1.22
- ARKR $9.78
- Average True Range (ATR)
- AKTX 0.08
- ARKR 0.26
- MACD
- AKTX -0.00
- ARKR -0.10
- Stochastic Oscillator
- AKTX 40.00
- ARKR 33.68
About AKTX Akari Therapeutics plc ADS
Akari Therapeutics PLC is an oncology company developing next-generation antibody-drug conjugates (ADCs) designed around novel, proprietary cancer-killing toxins (payloads). The company believes these novel payloads may have the potential to transform the efficacy and safety outcomes of ADCs as cancer therapies beyond options that are currently available or in development. Its lead product candidate is AKTX-101, a preclinical stage Trop2-targeting ADC that combines PH1 with the Trop2 antibody, which is expressed in the highest number of solid tumor cancer types, including lung, breast, colon and prostate.
About ARKR Ark Restaurants Corp.
Ark Restaurants Corp owns and operates around 17 restaurants and bars, 16 fast food concepts, and catering operations in the USA. The Las Vegas operations include New York Hotel & Casino Resort, hotel room service operations, banquet facilities, employee dining room, food court concepts, and a restaurant within the Planet Hollywood Resort and Casino. It operates a restaurant and a bar in the Resorts Atlantic City Hotel and Casino and a restaurant in the Tropicana Hotel and Casino. The Florida operations include The Rustic Inn in Dania Beach, Shuckers in Jensen Beach, JB's on the Beach in Deerfield Beach, The Blue Moon Fish Company in Fort Lauderdale, and fast food facilities in Tampa and Hollywood. In Alabama, it operates Original Oyster Houses in Gulf Shores and Spanish Fort.